Screening large-cap Health Care names using earnings yield plus ROTC identified five undervalued blue-chip stocks over $100B market cap. Merck, Bristol-Myers, Gilead, Pfizer, and Amgen screen as the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback